GEZIELTE OLIGONUKLEOTIDE

European patent · EP3328873 · In force

Register entry

Publication number
EP3328873
Application number
EP16831384
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 28, 2016
Published
Jun 6, 2018
Granted
Sep 17, 2025
Protection ends at the latest
Jul 27, 2036
Next annual fee due
Jul 31, 2027
IPC classes
G01N 33/50 (2006.01)
C12N 15/113 (2010.01)
C07H 21/02 (2006.01)
Priority
US 201562198051 P 28.07.2015
US 201562198110 P 28.07.2015
US 201562220652 P 18.09.2015
US 201562239226 P 08.10.2015
US 201562269671 P 18.12.2015
US 201662305536 P 09.03.2016
PCT application
PCT/US2016/044595 28.07.2016
PCT publication
WO2017/019918 02.02.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Jul 29, 2026

    Change

    Published in Swissreg on 29.07.2026

  3. Oct 6, 2025

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 06.10.2025

  4. Sep 17, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.09.2025

Parties

Holder

Caris Science, Inc.

750 West John Carpenter Freeway, Suite 800, Irving, TX 75039, US

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

O'NEILL, Heather

Mesa, AZ 85202, US

MAYER, Gunter

53123 Bonn, DE

MIGLARESE, Mark

Phoenix, AZ 85048, US

SPETZLER, David

Paradise Valley, AZ 85253, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.